Established on January 2, 2004
Most recently revised on January 8, 2018

Copyright

Copyright for all published materials is owned by the Korea Health Personnel Licensing Examination Institute (formerly the National Health Personnel Licensing Examination Board of Korea). The corresponding author should agree to the transfer of copyright during the submission process. By default, the Editorial Board assumes that the co-authors also accept the copyright transfer upon acceptance by the corresponding author, who has the responsibility of submitting the copyright transfer agreement to the publisher.

Open access policy and license agreement

The Journal of Educational Evaluation for Health Professions (JEEHP) is an open access journal. Articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To use the tables or figures of JEEHP in other periodicals, books, or media for scholarly, educational, or even commercial purposes, no request of permission to the publisher of JEEHP is necessary. This aligns with the Budapest Open Access Initiative's definition of open access.
JEEHP also adheres to the open access policy of PubMed Central at the United States National Library of Medicine (http://www.ncbi.nlm.nih.gov/pmc/).
All contents of the journal are available immediately upon publication, with no embargo period.

Archiving policy

The full text of JEEHP has been archived in PubMed Central (PMC)/Europe PMC (http://www.ncbi.nlm.nih.gov/pmc/journals/834/) from the third volume (2006) and the National Library of Korea from the first volume (2004) (https://www.nl.go.kr/archive/search_eng.do?op=all&kwd=1975-5937). In the event that the journal is no longer published, JEEHP provides electronic backup and preservation of access to the journal content through archiving in PubMed Central or National Library of Korea.

Article deposit policy (article sharing policy)

According to the deposit policy of Sherpa/Romeo (http://www.sherpa.ac.uk/), authors cannot deposit pre-refereeing submitted versions of manuscripts to institutional repositories, but they can deposit post-refereeing accepted drafts or final versions of a manuscript. Additionally, authors can deposit the publisher’s version or PDF.

Detailed description of the use of JEEHP articles

□ Reader Benefit: The publisher applies the Creative Commons Attribution License to published works and allows free, immediate access to original works of all types.

□ Reuse Benefit: The publisher applies the Creative Commons Attribution License to published works and allows unrestricted reuse of original works of all types.

□ Copyright: The publisher applies the Creative Commons Attribution License to published works. Under this license, although the publisher owns the copyright, anyone can download, reuse, reprint, modify, distribute and/or copy the contents.

□ Author Posting Benefit: The publisher applies the Creative Commons Attribution License to published works. Under this license, although the publisher owns the copyright, authors are allowed to post the post-print or final PDF versions of articles.

□ Automatic Posting: The publisher immediately deposits the accepted articles in PubMed Central (http://pubmedcentral.org/) and the JEEHP homepage (http://jeehp.org) upon publication.

□ Machine Readability: JEEHP articles can be accessed programmatically through PubMed Central or Europe PMC’s RESTful Web Service (https://europepmc.org/RestfulWebService). For inquiries, please reach out via http://jeehp.org/about/inquiries.php.

Open data policy (Data sharing policy)

To facilitate verification of the accuracy and reproducibility of study results, raw or analyzed data will be deposited to a public repository, such as Harvard Dataverse (https://dataverse.harvard.edu/dataverse/jeehp/), after acceptance of the manuscript.
Therefore, submission of the raw or analyzed data is mandatory. If the data are already public, the relevant website URL or sources should be disclosed. If the data cannot be publicized, this can be negotiated with the editor. Authors with inquiries about data deposition should contact the editorial office.

Clinical data sharing policy

This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors” (https://doi.org/10.3346/jkms.2017.32.7.1051). As of July 1, 2018 manuscripts submitted to ICMJE journals that report the results of interventional clinical trials must contain a data sharing statement as described below. Clinical trials that begin enrolling participants on or after January 1, 2019 must include a data sharing plan in the trial's registration. The ICMJE's policy regarding trial registration is explained at https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record. All of the authors of research articles that deal with interventional clinical trials must submit data sharing plan of example 1 to 4 in Table 1. Based on the degree of sharing plan, authors should deposit their data after deidentification and report the DOI of the data and the registered site. This journal adheres to the data sharing policy described in the publication “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors” (https://doi.org/10.3346/jkms.2017.32.7.1051). As of July 1, 2018, manuscripts submitted to International Committee of Medical Journal Editors (ICMJE) journals that report the results of interventional clinical trials must contain a data sharing statement, as described below. Clinical trials that began enrolling participants on or after January 1, 2019 must include a data sharing plan in the trial registration. The ICMJE’s policy regarding trial registration is explained at https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html. If the data sharing plan changes after registration, this should be reflected in the submitted statement, published along with the manuscript, and updated in the registry record. All authors of research articles that deal with interventional clinical trials must submit a data sharing plan in the structure of examples 1 to 4 (Table 1). Based on the details of the sharing plan, authors should deposit their data after deidentification and report the DOI of the data and the registered website.

Table 1.   Examples of data sharing statements that fulfill ICMJE requirements*

Element	Example 1	Example 2	Example 3	Example 4
Will individual participant data be available (including data dictionaries)?	Yes	Yes	Yes	No
What data in particular will be shared?	All individual participant data collected during the trial, after deidentification.	Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).	Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).	Not available
What other documents will be available?	Study protocol, statistical analysis plan, informed consent form, clinical study report, analytic code	Study protocol, statistical analysis plan, analytic code	Study protocol	Not available
When will data be available (start and end dates)?	Immediately following publication. No end date.	Beginning at 3 months and ending at 5 years following article publication.	Beginning at 9 months and ending at 36 months following article publication.	Not applicable
With whom?	Anyone who wishes to access the data.	Researchers who provide a methodologically sound proposal.	Investigators whose proposed use of the data has been approved by an independent review committee (“learned intermediary”) identified for this purpose.	Not applicable
For what types of analyses?	Any purpose	To achieve aims in the approved proposal.	For individual participant data meta-analysis.	Not applicable
By what mechanism will data be made available?	Data are available indefinitely at (link to be included).	Proposals should be directed to xxx@yyy. To gain access, data requestors will need to sign a data access agreement.	Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our university’s data warehouse but without investigator support other than deposited metadata.	Not applicable
		Data are available for 5 years at a third-party website (link to be included).	Information regarding submitting proposals and accessing data may be found at (link to be provided).

ICMJE = International Committee of Medical Journal Editors.
*These examples are meant to illustrate a range of, but not all, data sharing options.